Suppr超能文献

一些稠合嘧啶类和相关杂环的合成及抗癌活性。

Synthesis and anticancer activity of some fused pyrimidines and related heterocycles.

机构信息

Chemistry Department, Faculty of Science, Princess Nora Bint, AbdulRahman University, Riyadh, Saudi Arabia.

出版信息

Saudi Pharm J. 2013 Jul;21(3):305-16. doi: 10.1016/j.jsps.2012.09.002. Epub 2012 Oct 24.

Abstract

On account of the reported anticancer of pyrimidine and condensed pyrimidine, a new pyrimido [3,2-b]-1,2,4,5-tetrazine 3a , b , 5c , d , 6, 9, pyrimido [3,2-b]-1,2,4-triazine 10, 11, pyrimido [3,2-b]-1,2,4-triazole 12 and pyrimidine derivatives 1,2a , b , 4c , d , 8, 13, 14, 15 and 16 were synthesized through different chemical reactions. Structures of all synthesized compounds were supported by spectral and elemental analyses. The obtained compounds were evaluated for their in vitro antitumor activity against human liver cancer cell line (HEPG2).

摘要

鉴于嘧啶和稠合嘧啶的抗癌报道,我们通过不同的化学反应合成了一种新的嘧啶并[3,2-b]-1,2,4,5-四嗪 3a、b、5c、d、6、9、嘧啶并[3,2-b]-1,2,4-三嗪 10、11、嘧啶并[3,2-b]-1,2,4-三唑 12 和嘧啶衍生物 1、2a、b、4c、d、8、13、14、15 和 16。所有合成化合物的结构均通过光谱和元素分析得到支持。对获得的化合物进行了体外抗人肝癌细胞系(HEPG2)的抗肿瘤活性评价。

相似文献

引用本文的文献

6
Therapeutic potential of heterocyclic pyrimidine scaffolds.杂环嘧啶支架的治疗潜力。
Chem Cent J. 2018 Apr 4;12(1):38. doi: 10.1186/s13065-018-0406-5.

本文引用的文献

2
Targeting RSK: an overview of small molecule inhibitors.靶向RSK:小分子抑制剂概述
Anticancer Agents Med Chem. 2008 Oct;8(7):710-6. doi: 10.2174/187152008785914770.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验